Leupromak Depot 3.75 mg Injection 1's belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis. Additionally, it is also used to treat precocious puberty (early puberty) in children. Leupromak Depot 3.75 mg Injection 1's is used in combination with other medicines to treat anaemia caused by uterine fibroids.

Leupromak Depot 3.75 mg Injection 1's contains Leuprolide acetate, which is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell growth in prostate cancer and helps treat endometriosis.

Leupromak Depot 3.75 mg Injection 1's will be administered by a healthcare professional. The common side effects of Leupromak Depot 3.75 mg Injection 1's include hot flashes, decreased sexual interest, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Avoid taking Leupromak Depot 3.75 mg Injection 1's if you are pregnant or breastfeeding. Both women and men using Leupromak Depot 3.75 mg Injection 1's should use effective contraception. Leupromak Depot 3.75 mg Injection 1's may affect fertility, hence discuss with your doctor if you have any plans to start a family in the future. Leupromak Depot 3.75 mg Injection 1's is not recommended for children below two years of age. Leupromak Depot 3.75 mg Injection 1's may cause dizziness, hence drive only if you are alert.

Leupromak Depot 3.75 mg Injection 1's is used in the treatment of Prostate cancer, Endometriosis, and Precocious puberty. The detailed uses of Leupromak Depot 3.75 mg Injection 1's are as follows:

• Treat advanced prostate cancer: Leupromak Depot 3.75 mg Injection 1's is primarily used to manage symptoms of advanced prostate cancer by lowering testosterone levels, which slows the growth of cancer cells.
• Manage endometriosis and uterine fibroids: Leupromak Depot 3.75 mg Injection 1's helps reduce estrogen production, alleviating pain and other symptoms associated with endometriosis and fibroids, and may be used preoperatively to shrink fibroid size.
• Treat central precocious puberty (CPP): Leupromak Depot 3.75 mg Injection 1's is prescribed for children with CPP to delay early onset of puberty and normalize growth and sexual development.
• Support fertility treatments and hormone regulation: Leupromak Depot 3.75 mg Injection 1's is used in assisted reproductive technologies to control hormone levels and prevent premature ovulation during fertility procedures.
• Treat anemia caused by uterine fibroids: In combination with other medications, Leupromak Depot 3.75 mg Injection 1's helps improve hemoglobin levels by reducing menstrual bleeding linked to fibroids.

• Follow your doctor's recommendations on the dosage and timing of this medication to achieve optimal results.
• Leupromak Depot 3.75 mg Injection 1's will be administered by a healthcare professional.
• Do not self-administer.

Leupromak Depot 3.75 mg Injection 1's contains Leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Leupromak Depot 3.75 mg Injection 1's is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Leupromak Depot 3.75 mg Injection 1's works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Leupromak Depot 3.75 mg Injection 1's reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helping in endometriosis.

If you are allergic to Leupromak Depot 3.75 mg Injection 1's or any other medicines, please tell your doctor. Leupromak Depot 3.75 mg Injection 1's is not indicated for use in pregnancy and breastfeeding women. If you are using Leupromak Depot 3.75 mg Injection 1's, make sure to use reliable forms of contraception. Leupromak Depot 3.75 mg Injection 1's may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Leupromak Depot 3.75 mg Injection 1's is not recommended for children younger than two years of age. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Leupromak Depot 3.75 mg Injection 1's, let your doctor know if you have liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Leupromak Depot 3.75 mg Injection 1's may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Leupromak Depot 3.75 mg Injection 1's. Leupromak Depot 3.75 mg Injection 1's can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.